Indoleamine 2,3-diooxygenase in periaortic fat: Mechanisms of inhibition of contraction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 4, 2011, Pages

  Watts, Stephanie W ^a   Shaw, Samantha ^a   Burnett, Robert ^a   Dorrance, Anne M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Angiotensin II; Brown fat; Immunosupression; Kynurenine; Tryptophan

Indexed keywords

1 LEVO METHYLTRYPTOPHAN; INDOLE DERIVATIVE; INDOLEAMINE 2,3 DIOXYGENASE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; AORTA; AORTA MEDIA; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERIAORTIC FAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPERIOR MESENTERIC ARTERY; THORACIC AORTA;

ACRIDINES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA INTERPRETATION, STATISTICAL; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISOMETRIC CONTRACTION; MALE; MESENTERIC ARTERY, SUPERIOR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; TRYPTOPHAN; VASOCONSTRICTOR AGENTS;

EID: 80053246383     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00384.2011     Document Type: Article

References (73)

1. Ball HJ, Sanchez-Perez A, Weiser S, Austin CJB, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermin LS, Hunt NH. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396: 203-213, 2007.
2. Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH. Indoleamine 2,3-dioxygenase-2: new enzymes in the kynurenine pathway. Int J Biochem Cell Biol 41: 467-471, 2009.
3. Barbarroja N, Lopez-Pedrera R, Mayas MD, Garcia-Fuentes D, Garrido- Sanchez L, Macias-Gonzalez M, El beka R, Vidal-Puig A, Tinahones FJ. The obese healthy paradox: is inflammation the answer? Biochem J 430: 141-149, 2010.
4. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, Alvarez- Cardona JA, Pruitt IE, Rhee EP, Colvin RA, Gerszten RE. Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem 284: 19189-19195, 2009.
5. Brandes RP. The fatter the better: perivascular adiopose tissue attenuates vascular contraction through different mechanisms. Br J Pharmacol 151: 303-304, 2007.
6. Braun D, Longman RS, Albert ML. A two step induced of indoleamine 2,3 dioxygenase (IDO) activity during dendritic cell maturation. Blood 106: 2375-2381, 2005.
7. Cady SG, Sono M. 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan) and β-[3-benzo(b)thienyl]-DLalanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Archiv Biochem Biophys 291: 326-333, 1991.
8. Chiba S, Katsuragi I, Simada T, Adachi I, Satoh Y, Noguchi H, Gotoh K, Tsubone T, Fujiwara K, Masaki T, Kakuma T, Kang M, Tanaka K, Hamaguchi K, Wada C, Yoshimatus H. Evaluation of human brown adipose tissue using positron emission tomography, computerized tomography and histochemical studies in association with body mass index, visceral fat accumulation and insulin resistance (Abstract). Obes Rev 7, Suppl 2: 87, 2006.
9. Christen T, Sheikine Y, Rocha VZ, Hurwitz S, Goldfine AB, Di Carli M, Libby P. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. J Am Coll Cardiol Img 3: 843-851, 2010.
10. Cigolini M, Bonora E, Querena M, Moghetti P, Cacciatori V, Zancanaro C, Benati D, Muggeo M. Differences in glucose metabolic enzyme activities in human adipose tissue from abdominal and gluteal regions. Metabolism 37: 820-823, 1988.
11. Cinti S. The adipose organ. Prostgl Leukotr Ess Fatty Acids 73: 9-15, 2005.
12. Csayni G, Taylor WR, Pagano PJ. NOX and inflammation in the vascular adventitia. Free Radic Biol Med 47: 1254-1266, 2009.
13. Cuffy MC, Silverio AM, Qin L, Wang Y, Eid R, Brandacher G, Lakkis FG, Fuchs D, Pober JS, Tellides G. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon- contributes to medial immunoprivilege. J Immunol 179: 5246-5254, 2007.
14. Curti A, Travanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygeanase in the induction of immune tolerance: focus on hematology. Blood 113: 2394-2401, 2009.
15. Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Cur Opin Endocrinol Diabetes Obes 17: 143-149, 2010.
16. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo F, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360: 1509-1517, 2009.
17. Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese vs. lean adults. Am J Cardiol 91: 195-199, 2003.
18. Darlington LG, Mackay GM, Forrest CM, Stoy N, Georg C, Stone TW. Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26: 2211-2221, 2007.
19. Dashwood MR, Dooley A, Shi-Wen X, Abraham DJ, Souza DS. Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery? J Vasc Res 44: 175-181, 2007.
20. Dlaskova A, Clarke KJ, Porter RK. The role of UCP1 in production of reactive oxygen species by mitochondria isolated from brown adipose tissue. Biochim Biophysica Acta 1797: 1470-1476, 2010.
21. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 286: H1107-H1113, 2004.
22. Enerback S. Human brown adipose tissue. Cell Met 11: 248-252, 2010.
23. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P. T cell apoptosis by tryptophan catabolism. Cell Death Diff 9: 1069-1077, 2002.
24. Fang L, Zhao J, Chen Y, Ma T, Xu G, Tang C, Liu X, Geng B. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens 27: 2174-2185, 2009.
25. Fesus G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, Gollasch M. Adiponectin is a novel humoral vasodilator. Cardiovasc Res 75: 719-727, 2007.
26. Galvez-Prieto B, Dubrovska G, Cano MV, Delgado M, Aranguez I, Gonzales MC, Ruiz-Gayo M, Gollasch M, Fernandez-Alfonso MS. A reduction in the amount and anticontractile effect of periaventitial mesenteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens Res 31: 1415-1423, 2008.
27. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, Lee RM. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71: 363-373, 2006.
28. Gil-Ortega M, Stucchi P, Guzman-Ruiz R, Cano V, Arribas S, Gonzalez MC, Ruiz-Gayo M, Fernandez-Alfonso MS, Somoza B. Adaptive nitric oxide overproduction in perivascular adipose tissue during early diet induced obesity. Endocrinology 151: 3299-3306, 2010.
29. Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci 25: 647-653, 2004.
30. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. J Exper Med 204: 2449-2460, 2007.
31. Hansen AM, Ball HJ, Mitchell AJ, Miu J, Takikawa O, Hunt NH. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localized to the vascular endothelium. Internat J Parasitol 34: 1309-1319, 2004.
32. Hirata F, Hayaishi O. Studies on indoleamine 2,3-dioxygenase; superoxide anion as substrate. J Biol Chem 250: 5960-5966, 1975.
33. Ichiki T. Perivascular adipose tissue, a janus-faced regulator of vascular function. Circ J 7: 1300-1301, 2010.
34. Keskin DB, Marshall B, Munn D, Mellor A, Gerhart DA. Decreased protein nitration in macrophages that overexpress indoleamine 2,3-dioxygenase. Cell Mol Biol Lett 12: 82-102, 2007.
35. Ketonen J, Shi J, Martonen E, Mervaala E. Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479-1487, 2010.
36. Lee RM, Lu C, Su LY, Gao YJ. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens 27: 782-790, 2009.
37. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart study. Atherosclerosis 210: 656-661, 2010.
38. Lob S, Konigsrainer A, Rammensee HG, Opelz G, Terness P. Inhibitors of indoleamine 2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9: 445-452, 2009.
39. Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P. Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 111: 2152-2154, 2008.
40. Lohmann C, Schafer N, von Lukowicz T, Stein MAS, Boren J, Rutti S, Wahli W, Donath MY, Luscher TF, Matter CM. Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver and pancreatic islets. Atherosclerosis 207: 360-367, 2009.
41. Lohn M, Dubrovska G, Lauterback B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 16: 1057-1063, 2002.
42. Lu C, Su LY, Lee RM, Gao YJ. Alterations in perivascular adipose tissue structure and function in hypertension. Eur J Pharmacol 656: 68-73, 2011.
43. Maghzal GJ, Thomas SR, Hunt NR, Stocker R. Cytochrome b5, but not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. J Biol Chem 288: 12014-12025, 2008.
44. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the knurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11: 198-209, 2008.
45. Montani JP, Carroll FJ, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogeneis of cardiovascular diseases. Int J Obesity 28: S58-S65, 2004.
46. Munn DH, Sharma MD, Lee JR, Javer KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL, Mellor AL. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870, 2002.
47. Naftilan AJ, Zuo WM, Inglefinger J, Ryan TJ, Pratt RE, Dzau VJ. Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest 87: 1300-1311, 1991.
48. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293: E444-E452, 2007.
49. Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW. The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43: 770-781, 2004.
50. Niinisalo P, Raitala A, Pertovaara M, Oja SS, Lehtimaki T, Kahonen M, Reunanen A, Jula A, Moilanen L, Kesaniemi YA, Nieminem MS, Hurme M. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest 68: 767-770, 2008.
51. Oelkrug R, Kutschke M, Meyer CW, Heldmaier G, Jastroch M. Uncoupling protein 1 decreases superoxide production in brown adipose tissue mitochondria. J Biol Chem 285: 21961-21968, 2010.
52. Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, Isobe KI, Nagase F. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF- B and the generation of reactive oxygen species. J Cell Biochem 108: 716-725, 2009.
53. Pawlak D, Tankiewicz A, Matys T, Buczko W. Peripheral distribution of kynureninemetabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol 54: 175-189, 2003.
54. Payne GA, Bohlen HG, Dincer UD, Borbouse L, Tune JD. Periadventitial adipose tissue impairs coronary endothelial function via PKC-β-dependent phosphorylation of nitric oxide synthase. Am J Physiol Heart Circ Physiol 297: H460-H465, 2009.
55. Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B, Nedergaard J. Chronic peroxisome proliferator-activated receptor γ (PPAR-γ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP-1 containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285: 7153-7164, 2010.
56. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity promotes inflammation in periaortic adipose tissue and angiotensin IIinduced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 29: 1458-1464, 2009.
57. Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, Takikawa O, Munn DH, Gendelman HE, Persidsky Y. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 106: 2383-2390, 2005.
58. Rohrig UF, Awad L, Grosdidier A, Larrieu P, Stroobant V, Colau D, Cerundolo V, Simpson AJ, Vogel P, Van den Eynde BJ, Zoete V, Michielin O. Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem 53: 1172-1189, 2010.
59. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 153: 907-917, 2007.
60. Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 13: 277-296, 1991.
61. Sorensen RB, Berge-Hansen L, Junker N, Hansen CA, Hadrup SR, Schumacher TN, Svane IM, Becker JC, Straten P, Andersen MH. The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase. PLos ONE 4: e6910, 2009.
62. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 17: 115-130, 2010.
63. Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev 1: 609-620, 2002.
64. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y, Saito Y, Nagai R, Sata M. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 105: 906-911, 2009.
65. Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, Sata M. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Atheroscler Thromb Vasc Biol 30: 1576-1582, 2010.
66. Tellides G. Periadventitial fat: regional source of inflammation in atherosclerosis. Arch Pathol Lab Med 131: 346-347, 2007.
67. Thomas SR, Terentis AC, Cai H, Takikawa O, Levina A, Lay PA, Freewan M, Stocker R. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide. J Biol Chem 282: 23778-23787, 2007.
68. Vela D, Buja M, Madjid M, Burke A, Naghavi M, Willerson JT, Casscells SW, Litovsky S. The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med 131: 481-487, 2007.
69. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 44: 271-276, 2004.
70. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF, Hunt NH, Stocker R. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Med 16: 279-287, 2010.
71. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 42: 468-473, 2003.
72. Yuasa HG, Ball HJ, Ho YF, Austin CJD, Whittington CM, Below K, Maghzal GJ, Jermiin LS, Hunt NH. Characterization and evolution of vertebrate indoleamine 2,3-dioxygenases IDOs from monotremes and marsupials. Comparative Biochem Physiol Part B 153: 137-144, 2009.
73. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signaling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365: 1817-1820, 2005.